| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/12/2002 | US20020127190 Mucoadhesive film, of a homogeneous mixture of a water-soluble polymer, a polyalcohol, a cosmetically and/or pharmaceutically active agent, and a flavor |
| 09/12/2002 | US20020127188 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid |
| 09/12/2002 | DE10111877A1 Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate New imidazolidine derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 09/12/2002 | DE10111058A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten New pharmaceutical compositions based on anticholinergics and NK¶1¶ receptor antagonists |
| 09/12/2002 | DE10110772A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren New pharmaceutical compositions based on anticholinergics and PDE IV inhibitors |
| 09/12/2002 | CA2440803A1 Modulators of chemokine receptor activity |
| 09/12/2002 | CA2440161A1 Inhibitor of monoamine uptake |
| 09/12/2002 | CA2440038A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439939A1 Novel aminodicarboxylic acid derivatives |
| 09/12/2002 | CA2439915A1 New pharmaceutical compositions based on anticholinergics and nk1-receptor antagonists |
| 09/12/2002 | CA2439859A1 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 09/12/2002 | CA2439854A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 09/12/2002 | CA2439852A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | CA2439849A1 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | CA2439832A1 Cyclosporins for the treatment of respiratory diseases |
| 09/12/2002 | CA2439779A1 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 09/12/2002 | CA2439691A1 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 09/12/2002 | CA2439647A1 Side-chain-halogenated aminodicarboxylic acid derivatives as medicaments for treatment of cardiovascular disorders |
| 09/12/2002 | CA2439628A1 Vaccine |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2438737A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | CA2434066A1 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 09/12/2002 | CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/11/2002 | EP1238979A1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same |
| 09/11/2002 | EP1238669A2 Neutrophil function inhibitors which contain glucosamine |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238071A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses |
| 09/11/2002 | EP1237917A2 Protein c derivatives |
| 09/11/2002 | EP1237902A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 09/11/2002 | EP1237891A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/11/2002 | EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/11/2002 | EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 09/11/2002 | EP1237878A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 09/11/2002 | EP1237877A2 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 09/11/2002 | EP1237876A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 09/11/2002 | EP1237874A2 Selective neurokinin antagonists |
| 09/11/2002 | EP1237868A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 09/11/2002 | EP1237867A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 09/11/2002 | EP1237851A2 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 09/11/2002 | EP1237845A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/11/2002 | EP1237575A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 09/11/2002 | EP1237548A1 Il-8 receptor antagonists |
| 09/11/2002 | EP1237546A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 09/11/2002 | EP1237544A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 09/11/2002 | EP0944614B1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 09/11/2002 | EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/11/2002 | EP0785789B1 Diazepino-indoles as phosphodiesterase iv inhibitors |
| 09/11/2002 | EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1368972A Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the inhibitor |
| 09/11/2002 | CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase |
| 09/11/2002 | CN1368969A Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 09/11/2002 | CN1368963A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/11/2002 | CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 09/11/2002 | CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives |
| 09/11/2002 | CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 09/11/2002 | CN1368953A Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha |
| 09/11/2002 | CN1368950A Novel aminobenzophenones |
| 09/11/2002 | CN1368946A New selective retinoid agonists |
| 09/11/2002 | CN1368853A Prophylactic dietary supplement based on milk |
| 09/11/2002 | CN1368368A Nano medicine 'Xiaokening' and its preparing process |
| 09/11/2002 | CN1368360A Nano medicine for treating icteroheptitis and its preparing process |
| 09/11/2002 | CN1368354A Nano medicine 'Xinyi Biyan' and its preparing process |
| 09/11/2002 | CN1368349A Nano medicine 'Huodan Biyan' and its preparing process |
| 09/11/2002 | CN1368348A Nano medicine 'Jinhou' and its preparing process |
| 09/11/2002 | CN1368343A Nano medicine 'Kanglebiyan' and its preparing process |
| 09/11/2002 | CN1368330A Nano medicine 'Yanreqing' and its preparing process |
| 09/11/2002 | CN1368329A Nano medicine 'Xiaoer Zhuhuang' and its preparing process |
| 09/11/2002 | CN1368327A Nano medicine 'Xiaoer Qingfeihuatan' and its preparing process |
| 09/11/2002 | CN1368324A Nano medicine 'Zhike' for relieving cough and its preparing process |
| 09/11/2002 | CN1368304A Nano medicine 'Yinchai' and its preparing process |
| 09/11/2002 | CN1368297A Nano medicine 'Jubeibanxia' and its preparing process |
| 09/11/2002 | CN1368296A Nano medicine 'Yanguo Zhike' and its preparing process |
| 09/11/2002 | CN1368289A Nano medicine 'Shexiang Qiying' and its preparing process |
| 09/11/2002 | CN1368286A Nano Antitrussive pear medicine and its preparing process |
| 09/11/2002 | CN1368278A Nano medicine 'Keling' and its preparing process |
| 09/11/2002 | CN1368276A Nano medicine 'Zhike Pipa' and its preparing process |
| 09/11/2002 | CN1368275A Nano medicine 'Zhike Taohua' and its preparing process |
| 09/11/2002 | CN1368274A Nano medicine 'Zhibao Lingzhi' and its preparing process |
| 09/11/2002 | CN1368273A Nano medicine 'Zhenzhu Niuhuang' and its preparing process |
| 09/11/2002 | CN1368272A Nano medicine 'Zhengjin' and its preparing process |
| 09/11/2002 | CN1368265A Nano medicine 'Xingsu' and its preparing process |
| 09/11/2002 | CN1368263A Nano medicine for treating infantile intractable cough and its preparing process |
| 09/11/2002 | CN1368262A Nano medicine for treating infantile pertussis and its preparing process |
| 09/11/2002 | CN1368261A Nano medicine 'Xiaoyanjiedu' and its preparing process |
| 09/11/2002 | CN1368257A Nano compound pear medicine and its preparing process |
| 09/11/2002 | CN1368252A Nano medicine 'Banfenghe' and its preparing process |
| 09/11/2002 | CN1368228A Nano medicine 'Baihua' and its preparing process |
| 09/11/2002 | CN1368226A Nano medicine 'Bushen Fangchuan' and its preparing process |
| 09/11/2002 | CN1368225A Nano medicine 'Beimuerdong' and its preparing process |